Keld Flintholm Jørgensen
Director/Board Member at SCANDION ONCOLOGY A/S
Profile
Keld Flintholm Jørgensen is currently an Independent Director at Scandion Oncology A since 2022 and a Senior VP & Head-Business Development at H.
Lundbeck A since 2019.
Previously, he worked as a Director-Strategic Partnering at Roche Pharma (Schweiz) AG.
He has an undergraduate and graduate degree from Copenhagen Business School.
Keld Flintholm Jørgensen active positions
| Companies | Position | Start |
|---|---|---|
| H. LUNDBECK A/S | Corporate Officer/Principal | 03/04/2019 |
| SCANDION ONCOLOGY A/S | Director/Board Member | 31/03/2022 |
Former positions of Keld Flintholm Jørgensen
| Companies | Position | End |
|---|---|---|
Roche Pharma (Schweiz) AG
 Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The private company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients. | Corporate Officer/Principal | - |
Training of Keld Flintholm Jørgensen
| Copenhagen Business School | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| H. LUNDBECK A/S | Health Technology |
| SCANDION ONCOLOGY A/S | Health Technology |
| Private companies | 1 |
|---|---|
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The private company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients. | Distribution Services |
- Stock Market
- Insiders
- Keld Flintholm Jørgensen
